Buscar
Mostrando ítems 11-20 de 467
Potencialidades do anticorpo anti-ID de Bevacizumabe 10.D7 que mimetiza VEGF
(Universidade Federal de São Paulo (UNIFESP), 2021)
Bevacizumab is a humanized monoclonal antibody (mAb) against vascular endothelial growth factor (VEGF), which plays an essential role in the tumor angiogenic process. The antibody is approved for use in the treatment of ...
VEGF-A and VEGFR2 expression in chicken myocardium treated with acetylsalicylic acid (AAS) Expresión de VEGF-A y VEGFR2 en miocardio de pollos tratados con ácido acetilsalicílico (AAS)
(Universidad de la Frontera, 2019)
The VEGF levels and its binding to its receptors are key stages in the regulation of angiogenesis. Acetylsalicylic acid (ASA), widely used in post-myocardial infarction treatment, has been shown to have an anti-angiogenic ...
Efectos de la co-estimulación con corticoides e IL-6 sobre la expresión y secreción de VEGF A en condrocitos murinos en etapa de diferenciación hipertrófica
(Universidad de Chile, 2015)
Resumen: La artritis reumatoidea juvenil (ARJ) es una enfermedad inflamatoria articular
autoinmune de alta prevalencia en la niñez y se caracteriza por un aumento de citoquinas
proinflamatorias tales como interleuquina-6 ...
Anti-VEGF for the Management of Diabetic Macular Edema
(Hindawi Publishing Corporation, 2014-01-01)
Diabetic retinopathy (DR) is an important cause of vision loss around the world, being the leading cause in the population between 20 and 60 years old. Among patients with DR, diabetic macular edema (DME) is the most ...
Catalytically inactive phospholipase A2 homologue binds to vascular endothelial growth factor receptor-2 via C-terminal loop region
(2008)
VEGF (vascular endothelial growth factor) regulates neovascularization
through binding to its receptorKDR(kinase insert domaincontaining
receptor; VEGF receptor-2). We recently identified
a catalytically inactive PLA2 ...
Catalytically inactive phospholipase A2 homologue binds to vascular endothelial growth factor receptor-2 via C-terminal loop region
(2008)
VEGF (vascular endothelial growth factor) regulates neovascularization
through binding to its receptorKDR(kinase insert domaincontaining
receptor; VEGF receptor-2). We recently identified
a catalytically inactive PLA2 ...
N-acetylglucosaminidase, myeloperoxidase and vascular endothelial growth factor serum levels in breast cancer patients
(Elsevier B.V., 2014-03-01)
Inflammatory cells surround breast carcinomas and may act promoting tumor development or stimulating anti-tumor immunity. N-acetylglucosaminidase (NAG) has been employed to detect macrophage accumulation/activation. ...